Connection
Daniel Bowles to Drugs, Investigational
This is a "connection" page, showing publications Daniel Bowles has written about Drugs, Investigational.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.772 |
|
|
|
-
Bowles DW, Kessler ER, Jimeno A. Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib). Drugs Today (Barc). 2011 Nov; 47(11):857-68.
Score: 0.394
-
Bowles DW, Jimeno A. New phosphatidylinositol 3-kinase inhibitors for cancer. Expert Opin Investig Drugs. 2011 Apr; 20(4):507-18.
Score: 0.378